TerrAscend (TSNDF) Cash from Discontinued Operations (2022 - 2026)

TerrAscend's (TSNDF) quarterly Cash from Discontinued Operations came in at 165000.0 in Q1 2026, up 94.8% year-on-year from 84701.6 in Q1 2025, and up 47.28% on a QoQ basis from 313000.0 in Q4 2025.

TerrAscend (TSNDF) Cash from Discontinued Operations (2022 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 5 years of Cash from Discontinued Operations data on file, last reported at 165000.0 in Q1 2026.

  • On a quarterly basis, Cash from Discontinued Operations rose 94.8% year-over-year to 165000.0 in Q1 2026; TTM through Mar 2026 was 9389000.0, a 17.93% increase from a year earlier, with the FY2025 full-year figure at 12398000.0, down 49.99% from the prior year.
  • Cash from Discontinued Operations for Q1 2026 stood at 165000.0, up from 313000.0 in the prior quarter.
  • Over the last five years, Cash from Discontinued Operations for TSNDF reached as high as 2956000.0 in Q4 2024 and fell as low as 20757000.0 in Q4 2023.
  • Historically, Cash from Discontinued Operations has averaged 3095875.0 across 5 years, with a median of 1646500.0 in 2022.
  • Across the five-year window, Cash from Discontinued Operations sank 9378.08% in 2023 and surged 114.24% in 2024, its largest moves.
  • Year by year, Cash from Discontinued Operations stood at 219000.0 in 2022, then sank by 9378.08% to 20757000.0 in 2023, then jumped by 114.24% to 2956000.0 in 2024, then slumped by 110.59% to 313000.0 in 2025, then surged by 47.28% to 165000.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Discontinued Operations figures were 165000.0 in Q1 2026, 313000.0 in Q4 2025, and 4427000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Haleon 89.69 Bn 87.82 Bn - -
2 Teva Pharmaceutical Industries 35.84 Bn 32.10 Bn 1.97 Bn -
3 Zoetis 32.67 Bn 30.73 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.69 Bn 23.63 Bn 4.39 Bn -
5 United Therapeutics 23.12 Bn 20.97 Bn 648.10 Mn -
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.24 Bn 18.44 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.83 Bn 16.51 Bn 800.70 Mn -
9 Elanco Animal Health 12.64 Bn 12.22 Bn 785.00 Mn -
10 TerrAscend 157.69 Mn 157.22 Mn 34.60 Mn -165,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -165,000.00
Mar 31, 2026 -165,000.00
Dec 31, 2025 -313,000.00
Dec 31, 2025 -313,000.00
Sep 30, 2025 -4.43 Mn
Sep 30, 2025 -4.43 Mn
Jun 30, 2025 -4.48 Mn
Jun 30, 2025 -4.48 Mn
Mar 31, 2025 -3.17 Mn
Mar 31, 2025 -3.17 Mn
Dec 31, 2024 2.96 Mn
Dec 31, 2024 2.96 Mn
Sep 30, 2024 -4.05 Mn
Sep 30, 2024 -4.05 Mn
Jun 30, 2024 -7.18 Mn
Jun 30, 2024 -7.18 Mn
Dec 31, 2023 -20.76 Mn
Dec 31, 2023 -20.76 Mn
Sep 30, 2023 -496,000.00
Sep 30, 2023 -496,000.00